Phathom Pharmaceuticals Inc (NASDAQ:PHAT) currently has a daily average trading volume of 2.62M but it saw 3575664 shares traded in last market. With a market cap of 700.24M USD, the company’s current market price of $10.03 came rising about 10.95 while comparing to the previous closing price of $9.04. In past 52 weeks, the stock remained buoying in the range of price level as high as $19.71 and as low as $2.21. In the recent trading on the day, stock has struck highest price mark of $9.095 while lowest mark touched by it was $10.48.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which initiated the stock as “Overweight” in its note to investors issued on February 14, 2025, recommending a price target of $23 for it. Needham issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $23 and $26.
Over the week, PHAT’s stock price is moving 113.86% up while it is 203.02% when we observe its performance for the past one month. Year-to-date it is 23.52% up and over the past year, the stock is showing a downside performance of -6.61%.
Currently, Phathom Pharmaceuticals Inc’s total number of outstanding shares is 69.64M with 4.28% of that held by the insiders while 85.69% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -165.71%. Stock’s beta reads 0.15. Stock has a price to sale or P/S ratio amounts to 8.55. Its return on asset (ROA) is -106.28% on average.
